Skip to Content

Investor FAQs

Investor FAQs

Show All
When was Intec Pharma founded?
Intec Pharma Ltd. was established and incorporated in Israel on October 23, 2000 as a private Israeli company under the name Orly Guy Ltd. In February 2001, our name was changed to Intec Pharmaceuticals (2000) Ltd. In March 2004, we changed our corporate name to Intec Pharma Ltd.
Where are Intec Pharma’s shares traded?
Intec Pharma’s common stock is traded on the Nasdaq under the ticker symbol “NTEC” (IPO in August 2015). The shares previously traded on the Tel Aviv Stock Exchange (TASE) under the ticker symbol “NTEC” (IPO in 2010) and Intec Pharma delisted from the TASE in August 2018.
What is your stock’s CUSIP number?
The CUSIP number for Intec Pharma is M53644.
How many employees does Intec Pharma have?
The company currently has 80 full-time employees.
Where can I find Intec Pharma’s latest investor presentation?
The company’s most recent investor presentation is available in the “Investors” section on the company’s website. It can also be accessed at the “Events” page of the “Investors” section on the company’s website.
What financial analysts cover Intec Pharma?
Please refer to the “Analyst Coverage” section of the “Investor Relations” section.
When will Intec Pharma next report financial results?
The company expects to report its quarterly financial results within 45 days following the close of the quarter and its annual financial results within 90 days of the close of its fiscal year.
When is Intec Pharma's fiscal year end?
The fiscal year ends on December 31.
Has Intec Pharma ever had a stock split?
On March 29, 2015, when Intec Pharma's common stock was solely traded on the TASE, the Company executed a 50-to-1 reverse share split of the Company’s ordinary shares and eliminated their par value.
Can I buy Intec Pharma stock directly from the company?
Intec Pharma does not offer a direct stock purchase plan. Shares of the company can be purchased through a broker.
Does Intec Pharma issue dividends on its common stock?
Intec Pharma has never declared or paid cash dividends. The company intends to retain any future earnings for the operation and expansion of its business and does not anticipate paying any cash dividends in the foreseeable future.
When is Intec Pharma’s Annual Meeting of Stockholders?
The date and location will be published in the company’s proxy statement, which can be found on the “SEC Filings” section in the “Investors” section on the company’s website.
Where are Intec Pharma’s headquarters?
Intec Pharma Corporate Headquarters
12 Hartom St. (RMPE building) 
P.O. Box 45219
Jerusalem 9777512 Israel 
Telephone: + 972-2-5864657
Facsimile: + 972-2-5869176
Email: info@intecpharma.com 
Who is Intec Pharma's transfer agent?
VStock Transfer, LLC
18 Lafayette Place
Woodmere, New York 11598
Phone: (212) 828-8436 Ext. 120
Facsimile: (646) 536-3179
www.VStockTransfer.com
Who do I contact about replacement of stock certificates?
To replace lost certificates, please contact Intec Pharma’s transfer agent
Who should shareholders notify of a change in address?
To change your address, please contact Intec Pharma’s transfer agent.
Who is the investor relations contact?

Anne Marie Fields
VP-Corporate Communications & Investor Relations
Three Columbus Circle, 15th Floor
New York, NY 10019
646-200-8808
amf@intec-us.com 

Do you have any other questions?
Please submit your question using the form on the contact page.